On 4/26/24, Resmed Inc (NYSE: RMD) stock enjoyed a major increase of 18.9%, closing at $218.06. Moreover, exceptionally high trading volume at 380% of normal accompanied the advance. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 22.8% during the last week.
Current PriceTarget Research Rating
RMD is expected to continue to be a modest Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
Resmed has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Resmed has a very low Appreciation Score of 10 but a slightly positive Power Rating of 69, triggering the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment